ChainCatcher report: Andrei Grachev, co-founder of DWF Labs, responded to recent market speculation regarding DEXE trades, stating that all related transactions can be verified through centralized exchange records. Grachev outlined DWF Labs’ DEXE trading process as follows: substantial purchases of DEXE in 2024, partial sales for profit in 2025, another large purchase of DEXE around October 10, hedging profits in the first half of 2026, and being forced to close short positions when funding rates turned negative, followed by selling a portion of DEXE spot holdings to increase cash reserves. Grachev emphasized that all buy and sell operations were executed through centralized exchanges, which hold the relevant account data, and criticized certain paid KOLs for spreading misleading information.
DWF Labs Co-Founder Clarifies DEXE Trading Activities Amid Sell-Off Speculation
ChaincatcherShare
Summary
DWF Labs co-founder Andrei Grachev addressed recent speculation surrounding DEXE trading, emphasizing a disciplined approach aligned with value investing in crypto. He outlined significant DEXE purchases in 2024, partial sales in 2025, a second bulk purchase in early 2026, hedging strategies, and forced short liquidations. All trades were executed on centralized exchanges. Grachev noted that these trades maintained a strong risk-to-reward ratio and criticized paid KOLs for disseminating misleading narratives.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.